• $2.1M
    Market Cap
  • N/A
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
523,031
+16.70%
448,196
N/A
Cost of Revenue
195,680
+191.88%
67,041
N/A
Gross Profit
327,351
-14.12%
381,155
N/A
Sales and Marketing Expense
181,853
-40.87%
307,534
N/A
Research and Development Expense
-459,135
+391.98%
-93,324
N/A
Depreciation and Amortization Expense
N/A
N/A
59,718
N/A
Total Operating Expenses
5.5M
+378.91%
1.2M
N/A
Operating Profit
-5.2M
+573.40%
-770,266
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
Total Nonoperating Income and Expense
88,579
-32.64%
131,507
N/A
Income before Taxes
-5.1M
+698.17%
-638,759
N/A
Income Taxes
N/A
N/A
21,829
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-5.1M
+671.72%
-660,588
N/A
Net Income from Continuing Operations Applicable to Common
-5.1M
+698.17%
-638,759
N/A
Basic EPS and Net Income
-0.32
+511.54%
-0.05
N/A
Diluted EPS and Net Income
-0.32
+511.54%
-0.05
N/A
Basic Weighted Average Shares
16.0M
+26.07%
12.7M
N/A
Diluted Weighted Average Shares
16.0M
+26.07%
12.7M
N/A
Balance Sheet
Cash and Cash Equivalents
1.5M
-75.81%
6.2M
N/A
Short-Term Investments
1.4M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.9M
-52.50%
6.2M
N/A
Total Current Assets
4.1M
-38.77%
6.7M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
37,818
-17.05%
45,594
N/A
Total Long-Term Assets
5.0M
+10,883.59%
45,594
N/A
Total Assets
9.1M
+35.30%
6.7M
N/A
Income Taxes Payable
521,558
+1,495.86%
32,682
N/A
Total Short-Term Debt
142,998
-42.33%
247,969
N/A
Total Current Liabilities
462,817
-14.06%
538,551
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
507,015
N/A
N/A
N/A
Total Liabilities
969,832
+80.08%
538,551
N/A
Retained Earnings
-5.6M
+975.02%
-522,851
N/A
Total Stockholders Equity
6.1M
-1.00%
6.2M
N/A
Total Shares Outstanding
6.6M
0.00%
6.6M
N/A
Cash Flow
Cash from Operating Activities
-3.2M
+316.96%
-775,000
N/A
Capital Expenditures
3,806
+342.04%
861
N/A
Cash from Investing Activities
-1.4M
+156,944.02%
-861
N/A
Dividends Paid
8,907
N/A
N/A
N/A
Cash from Financing Activities
-91,645
-101.37%
6.7M
N/A
Financials Ratio
Gross Margin
62.59%
N/A
N/A
N/A
Operating Margin
-991.71%
N/A
N/A
N/A
Return on Assets
-64.45%
N/A
N/A
N/A
Return on Equity
-82.84%
N/A
N/A
N/A
Revenue Growth
16.70%
N/A
N/A
N/A
Current Ratio
8.83
N/A
N/A
N/A
Cash Ratio
3.22
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow